India Airport Stops St. Jude Medical CEO For Ammo Shell In Luggage
This article was originally published in PharmAsia News
Executive SummaryIndian authorities detained the CEO of U.S.-based St. Jude Medical, a major producer of medical devices, when airport security detected a bullet in his luggage
You may also be interested in...
US FDA declined stakeholder requests to remove recommendation for placebo controls from a final guidance but added qualifying language on their use ‘when feasible.’ While the agency excised language on biomarker validation from the final guidance, it reaffirmed the need for early establishment of critical quality attributes and critical process parameters.
Inclisiran's price relative to existing PCSK9 drugs will be key determinant in payer acceptance. Novartis says pricing will be within cost effectiveness range estimated by ICER.
The company said it will update investors on the path forward for zuranolone in major depressive disorder after finalizing discussions with the US FDA. It would not confirm if a meeting had taken place yet.